Compare SRRK & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRRK | MRCY |
|---|---|---|
| Founded | 2012 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.1B |
| IPO Year | 2018 | 1997 |
| Metric | SRRK | MRCY |
|---|---|---|
| Price | $45.04 | $77.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $55.40 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 1.1M | 458.2K |
| Earning Date | 03-03-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.69 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $912,020,000.00 |
| Revenue This Year | N/A | $6.59 |
| Revenue Next Year | $449.79 | $9.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.19 |
| 52 Week Low | $22.71 | $39.89 |
| 52 Week High | $49.82 | $103.81 |
| Indicator | SRRK | MRCY |
|---|---|---|
| Relative Strength Index (RSI) | 52.17 | 38.47 |
| Support Level | $41.54 | $73.21 |
| Resistance Level | $48.29 | $79.27 |
| Average True Range (ATR) | 2.49 | 4.38 |
| MACD | -0.28 | -0.94 |
| Stochastic Oscillator | 62.43 | 13.78 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.